VivoSim Labs Receives Nasdaq Notice Over Equity Requirement

What Happened
VivoSim Labs, Inc. (VIVS) announced on an 8‑K that on July 20, 2026 the Nasdaq Listing Qualifications Staff sent a notice saying the company did not meet Nasdaq Listing Rule 5550(b)(1)’s $2,500,000 minimum stockholders’ equity requirement. The company’s Annual Report on Form 10‑K for the period ended March 31, 2026 reported stockholders’ equity of $(1,099,000). VivoSim intends to file a plan to regain compliance within the required period; Nasdaq’s notice does not have any immediate effect on the listing or trading of VIVS.

Key Details

• Nasdaq notice date: July 20, 2026.
• Reported stockholders’ equity (10‑K for period ended March 31, 2026): $(1,099,000).
• Deadline to submit a compliance plan: 45 calendar days from July 20, 2026 (until September 3, 2026). If Nasdaq accepts the plan, an extension of up to 180 days from July 20 (until January 16, 2027) may be granted.
• The company states that, as of the date of the filing, its stockholders’ equity is now in excess of $2.5 million as a result of certain transactions; trading continues on the Nasdaq Capital Market under the ticker VIVS.

Why It Matters
This notice signals a regulatory compliance issue that could, if not resolved, lead to delisting proceedings under Nasdaq rules. For investors, the immediate effect is limited—shares remain listed and tradable—but the company must convince Nasdaq it will meet the minimum equity standard or obtain an extension. There is no assurance Nasdaq will accept the company’s plan, and failure to regain or maintain compliance could materially affect liquidity, marketability and investor confidence in VIVS stock.